Cost-effectiveness of remdesivir for the treatment of hospitalized patients with COVID-19: a systematic review

BACKGROUND: Remdesivir is being studied and used to treat coronavirus disease 2019 (COVID-19). This study aimed to systematically identify, critically evaluate, and summarize the findings of the studies on the cost-effectiveness of remdesivir in the treatment of hospitalized patients with COVID-19....

Descripción completa

Detalles Bibliográficos
Autores principales: Rezapour, Aziz, Behroozi, Zahra, Nasirzadeh, Mostafa, Rezaeian, Mohsen, Barzegar, Mohammad, Tashakori-Miyanroudi, Mahsa, Sayyad, Abdollah, Souresrafil, Aghdas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Scoping Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116457/
https://www.ncbi.nlm.nih.gov/pubmed/37081575
http://dx.doi.org/10.1186/s40249-023-01092-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10116457/
https://www.ncbi.nlm.nih.gov/pubmed/37081575
http://dx.doi.org/10.1186/s40249-023-01092-1

Ejemplares similares